Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis

Japanese Journal of Nephrology

Volumn 42, Issue 2, 2000, Pages 60-65

  Hasegawa, Shigeru ^a   Iesato, Kenji ^a   Tsukahara, Tsunemichi ^a   Yamamoto, Shunichi ^a   Kondou, Yoichirou ^a   Ogawa, Makoto ^b   Ueda, Shirou ^b  

^a Chiba Social Insurance Hospital   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Angiotensin II receptor antagonist; Losartan; Scleroderma renal crisis; Systemic sclerosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; METHYLPREDNISOLONE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; DYSPNEA; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; PLASMA RENIN ACTIVITY; RENOVASCULAR HYPERTENSION; SCLERODERMA; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; KIDNEY FAILURE, ACUTE; LOSARTAN; MALE; RECEPTORS, ANGIOTENSIN; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 0034077878     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Steen VD, Medsger TA, Osial Jr TA, Ziegler GL, Shapiro AP, Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 1984 ; 76 : 779-86.
2. Steen VD, Costarino JP, Shapiro AP, Medsger TA. Outcome of renal crisis in systemic sclerosis : Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990 ; 113 : 352-7.
3. Giovannetti R, Corso CD, Galeone F, Giuntoli F, Saba P. Efficacy and safety of losartan in hypertensive patients with side effects induced by other antihypertensive agents. Curr Ther Res 1997 : 851-8.
4. Caskey FJ, Thacker EJ, Jhonston PA, Barnes JN. Failure of losartan to control blood pressure in scleroderma renal crisis. Lancet 1997 ; 349 : 620.
5. Traub YM, Shapiro AP, Rodman GP, Medsger TA, McDonald Jr RH, Steen VD, Oial Jr TA, Tolchin SF. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Medicine 1983 ; 62 : 335-52.
6. Sanders PW, Herrere GA, Ball GV. Acute renal failure without fibrotic skin changes in progressive systemic sclerosis. Nephron 1988 ; 48 : 121-5.
7. Zwettler U, Andrassy K, Waldherr R, Ritz E. Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kid Dis 1993 ; 22 : 53-6.
8. Helfrich DJ, Banner B, Steen VD, Medsger TA. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989 ; 32: 1128-34.
9. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic antibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994 ; 21 : 864-70.
10. Donohoe JF. Scleroderma and the kidney. Kidney Int 1992 ; 41 : 462-77.
11. Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 1995 ; 75 : 793-5.
12. Goldsmith DJA. Angiotensin receptor antagonists. Lancet 1997 ; 349 : 1225.